Trial Profile
A retrospective study evaluating long-term efficacy and safety of golimumab in the treatment of patients with multirefractory Behcet's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Aug 2018
Price :
$35
*
At a glance
- Drugs Golimumab (Primary)
- Indications Behcet's syndrome
- Focus Therapeutic Use
- 03 Aug 2018 New trial record